| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Peter E Fecci | Q89573870 |
| John P. Kirkpatrick | Q43079202 | ||
| P2093 | author name string | Grace J Kim | |
| Gordana Vlahovic | |||
| Kimberly L Blackwell | |||
| April K S Salama | |||
| Jessica L Narloch | |||
| S Harrison Farber | |||
| Vadim Tsvankin | |||
| P2860 | cites work | Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial | Q48594003 |
| Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma | Q48616807 | ||
| Activation of stat3 in human melanoma promotes brain metastasis | Q48616814 | ||
| Extravasation of staphylococcal α-toxin in normal and injured CNS regions lacking blood-brain barrier function: observations after ventral root replantation | Q48654230 | ||
| Organ-specificity of the extravasation process: an ultrastructural study | Q48759657 | ||
| The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis | Q48822379 | ||
| Controversies in the management of patients with brain metastases. | Q48899249 | ||
| The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression | Q48925130 | ||
| Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas. | Q55479392 | ||
| Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase | Q74314831 | ||
| Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors | Q80579967 | ||
| Brain metastases | Q84586247 | ||
| Brain metastases | Q86996838 | ||
| The blood-brain barrier: bottleneck in brain drug development | Q22336985 | ||
| Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma | Q24615166 | ||
| Safety, activity, and immune correlates of anti-PD-1 antibody in cancer | Q24633070 | ||
| Genes that mediate breast cancer metastasis to the brain | Q24644008 | ||
| Targeting selectins and selectin ligands in inflammation and cancer | Q24658204 | ||
| Melanoma brain metastases: an unmet challenge in the era of active therapy | Q26995622 | ||
| Immunotherapy for primary brain tumors: no longer a matter of privilege | Q27002510 | ||
| A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules | Q27308814 | ||
| Structural and functional features of central nervous system lymphatic vessels | Q27316769 | ||
| Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases | Q27335558 | ||
| The vascular basement membrane as "soil" in brain metastasis | Q27348725 | ||
| Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
| The future of immune checkpoint therapy | Q28259862 | ||
| Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma | Q29615443 | ||
| Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 | ||
| T cell exhaustion | Q29620463 | ||
| Nivolumab and ipilimumab versus ipilimumab in untreated melanoma | Q29620657 | ||
| Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma | Q29620812 | ||
| A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis | Q30641737 | ||
| Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma | Q30890582 | ||
| Pathogenesis and vascular integrity of breast cancer brain metastasis | Q33267521 | ||
| Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial | Q33402830 | ||
| Current management of metastatic brain disease | Q33475484 | ||
| Real-time imaging reveals the single steps of brain metastasis formation | Q33519908 | ||
| Central nervous system pericytes in health and disease | Q33609398 | ||
| Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases | Q33620317 | ||
| Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. | Q33882549 | ||
| Reactive Astrocytes Protect Melanoma Cells from Chemotherapy by Sequestering Intracellular Calcium through Gap Junction Communication Channels | Q34105366 | ||
| Antibody-based immunotherapy for malignant glioma | Q34120472 | ||
| Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance | Q34241117 | ||
| Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer | Q34393640 | ||
| Nitric oxide-mediated tumoricidal activity of murine microglial cells | Q34398319 | ||
| Serpins promote cancer cell survival and vascular co-option in brain metastasis | Q34407528 | ||
| The seed and soil hypothesis: vascularisation and brain metastases | Q34571767 | ||
| Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 | ||
| Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study | Q34679120 | ||
| Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. | Q34853757 | ||
| Surgical management of melanoma brain metastases in patients treated with immunotherapy. | Q34954990 | ||
| Differential reactions of microglia to brain metastasis of lung cancer | Q35113715 | ||
| Integrin β4 signaling promotes mammary tumor cell adhesion to brain microvascular endothelium by inducing ErbB2-mediated secretion of VEGF. | Q35525904 | ||
| Macrophages: modulators of breast cancer progression. | Q35694234 | ||
| An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme | Q35800650 | ||
| Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites | Q35812429 | ||
| PD-1/PD-L1 inhibitors. | Q35893753 | ||
| Molecular MRI enables early and sensitive detection of brain metastases | Q35921996 | ||
| Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases | Q36082506 | ||
| Immunotherapy of malignant brain tumors | Q36162929 | ||
| IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival | Q36405905 | ||
| Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases | Q36562180 | ||
| Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model | Q36562978 | ||
| Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer | Q36721489 | ||
| Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells. | Q36813096 | ||
| The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. | Q37020840 | ||
| The controversial role of microglia in malignant gliomas | Q37091110 | ||
| Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization | Q37185154 | ||
| Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment | Q37268974 | ||
| Impact of stress and mast cells on brain metastases | Q37314523 | ||
| Ipilimumab and radiation therapy for melanoma brain metastases | Q37481186 | ||
| Cancer immunoediting in malignant glioma | Q37986999 | ||
| Mechanisms of immune evasion by gliomas | Q38013708 | ||
| Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival | Q38019011 | ||
| Role of the systemic immune system in brain metastasis | Q38052756 | ||
| Role of the blood-brain barrier in the formation of brain metastases | Q38076279 | ||
| Antitumor immune responses induced by ionizing irradiation and further immune stimulation | Q38139854 | ||
| Emerging insights into barriers to effective brain tumor therapeutics | Q38237653 | ||
| New therapeutic options for advanced non-resectable malignant melanoma. | Q38321800 | ||
| In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment | Q38543250 | ||
| The blood-brain barrier to proteins under normal and pathological conditions | Q39989136 | ||
| Brain microenvironment promotes the final functional maturation of tumor-specific effector CD8+ T cells | Q40196611 | ||
| TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells | Q40246842 | ||
| Blood-brain barrier: a definition of normal and altered function | Q40293389 | ||
| HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo | Q40405171 | ||
| Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option | Q40511146 | ||
| Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice | Q40550921 | ||
| Inflammatory cytokines in the brain: does the CNS shape immune responses? | Q40587473 | ||
| MICA/NKG2D-mediated immunogene therapy of experimental gliomas. | Q40604072 | ||
| Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis | Q40755079 | ||
| Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours | Q40796997 | ||
| Influence of adhesion molecule expression by human brain microvessel endothelium on cancer cell adhesion | Q41010916 | ||
| Modulation of GEF‐H1 Induced Signaling by Heparanase in Brain Metastatic Melanoma Cells | Q41375131 | ||
| An Experimental Model for Cerebral Metastasis Preliminary Light and Ultrastructural Studies | Q41504853 | ||
| Extravascular migration of tumor cells in the brain: an electron microscopic study. | Q42469994 | ||
| Successful treatment of melanoma brain metastases with adoptive cell therapy. | Q42933679 | ||
| Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. | Q43022293 | ||
| A phase 2 study of high-dose Allovectin-7 in patients with advanced metastatic melanoma | Q43114309 | ||
| Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma | Q44590636 | ||
| Regulatory T cells actively infiltrate metastatic brain tumors. | Q45853847 | ||
| Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial | Q46388451 | ||
| Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. | Q46831085 | ||
| Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas | Q48151249 | ||
| Active specific immunotherapy against occult brain metastasis. | Q48359056 | ||
| Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view | Q48400195 | ||
| Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases. | Q48485643 | ||
| Quantitative Study of Blood.Brain Barrier Permeability Changes after Experimental Whole-Brain Radiation | Q48552848 | ||
| Efflux of drugs and solutes from brain: the interactive roles of diffusional transcapillary transport, bulk flow and capillary transporters | Q48567276 | ||
| Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10. | Q48582022 | ||
| P433 | issue | 7 | |
| P304 | page(s) | e1172153 | |
| P577 | publication date | 2016-04-11 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | Embracing rejection: Immunologic trends in brain metastasis | |
| P478 | volume | 5 |
| Q91736550 | Brain immunology and immunotherapy in brain tumours |
| Q55283310 | Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. |
| Q92070127 | Immunomodulatory Drugs in Melanoma Brain Metastases |
| Q54950354 | Mechanisms and Therapy for Cancer Metastasis to the Brain. |
| Q92511346 | Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis |
| Q42362521 | Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System |
| Q64075498 | Turning "Cold" Into "Hot" Tumors-Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers |
Search more.